Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04219150Completed
Randomised, open-label trial in acute respiratory distress syndrome (ARDS) (2 arms), sponsored by Tanta University. Primary endpoint: Percentage of mortality at 28th day at 28 days. Started Jan 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04219150.